LungLife AI: Funding, Investors & Team (Oct 2026)
LungLife AI is a molecular diagnostics company dedicated to detecting and treating cancer early. Using machine learning and artificial intelligence, the company is able to provide life-saving early diagnosis of lung cancer. Their focus is on revolutionizing cancer diagnosis and management by utilizing AI for molecular analysis of cancer biomarkers in blood. LungLife AI is working on tests for all stages of lung cancer, from aiding in early diagnosis to monitoring late-stage disease. Through their diagnostic technology and machine learning techniques, the company is able to improve workflow efficiency and performance. Established in 2008, LungLife AI is based in Thousand Oaks, California.
LungLife AI has raised $320k across 1 funding round on record, the most recent an undisclosed round of $320k announced in Mar 2024.
That round is below the $6.0M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
LungLife AI Company Profile and Key Stats
Latest funding round on record: Mar 2024.
LungLife AI Funding Rounds
LungLife AI Founders and Leadership Team
No contact details are on record for this team yet.
LungLife AI Funding Compared to Other Artificial Intelligence Startups
LungLife AI's latest round of $320k is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like LungLife AI in Artificial Intelligence and Thousand Oaks
Companies Similar to LungLife AI
Gallatin is developing a logistics system that is tailored to the current requirements and limitations of the…
Nyne is the people data company. We deploy tens of millions of autonomous agents across the open web to…
Vinci utilizes generative artificial intelligence to create hardware design. Its services cover the design,…
Siena AI is an innovative customer service platform designed specifically for commerce. It combines the…
Factory is a developer of an AI-based platform for computer codes and software engineering. Its platform…
Ocular is a Cloud and Artificial Intelligence company, backed by Y Combinator, bringing Enterprise AI and…
Ghost is a consumer hardware and software company building a private, local-first computing system for…
Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial…
The EnCharge AI platform provides a reliable computing solution that enables the utilization of highly…
The hardest unsolved problem in robotics isn't perception or locomotion, it's dexterity. Tangent Robotics…
Autopoiesis Sciences creates advanced AI models that aim to enable groundbreaking scientific advancements…
LungLife AI Funding FAQs
What does LungLife AI do?
LungLife AI is a molecular diagnostics company dedicated to detecting and treating cancer early. Using machine learning and artificial intelligence, the company is able to provide life-saving early diagnosis of lung cancer. Their focus is on revolutionizing cancer diagnosis and management by utilizing AI for molecular analysis of cancer biomarkers in blood. LungLife AI is working on tests for all stages of lung cancer, from aiding in early diagnosis to monitoring late-stage disease. Through their diagnostic technology and machine learning techniques, the company is able to improve workflow efficiency and performance. Established in 2008, LungLife AI is based in Thousand Oaks, California.
How much funding has LungLife AI raised?
LungLife AI has raised $320k across 1 round on record. The most recent is an undisclosed round of $320k announced in Mar 2024.
When did LungLife AI last raise funding?
LungLife AI's most recent funding round on record is an undisclosed round of $320k, announced in Mar 2024.
Who founded LungLife AI?
FundedIQ lists Fred Gluck (Founder) at LungLife AI.
Where is LungLife AI headquartered?
LungLife AI is based in Thousand Oaks, California, United States.
How many employees does LungLife AI have?
LungLife AI is in the 11-50 employee band.
How does LungLife AI's funding compare to other Artificial Intelligence startups?
LungLife AI's latest round of $320k is below the $6.0M median round size for Artificial Intelligence companies on FundedIQ across 7,241 tracked companies over the last two years.
About FundedIQ's LungLife AI Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for LungLife AI is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.